Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Sep 28;20(12):1975–1981. doi: 10.1016/j.bbmt.2014.08.013

Figure 1. Transplant outcomes for recipients of haploidentical, matched related and 10/10 HLA matched unrelated donor transplants.

Figure 1

(A) All treated patients and (B) patients in remission at transplant. Progression free survival (PFS), overall survival (OS) and cumulative incidence of non-relapse mortality are shown. C) Multivariable analysis for progression free survival for patients in remission prior to transplant, in relation to age, cytogenetic risk (SWOG), melphalan dose, donor type (matched vs. haploidentical), and HCT-CI.